{
  "slug": "paradigm4",
  "name": "Paradigm4",
  "description": "Paradigm4 provides a platform that helps validate AI-driven hypotheses using multimodal data to accelerate target discovery efforts in the life sciences, reducing risk and building conviction for pharmaceutical and biotech companies.",
  "url": "https://optimly.ai/brand/paradigm4",
  "websiteUrl": "https://paradigm4.com/",
  "logoUrl": "https://logo.clearbit.com/paradigm4.com",
  "baiScore": 57.5,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "AI Drug Discovery & Development Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-25T20:38:50.908Z",
  "verifiedVitals": {
    "website": "https://paradigm4.com",
    "category": "Life Sciences Data Platform, Biomedical Analytics, AI/ML in Drug Discovery",
    "what_it_does": "Paradigm4 is a tech-enabled data science company that provides a multimodal evidence platform to global life science firms. It helps accelerate disease understanding and drug discovery by enabling partners to find novel targets, validate AI results, and generate evidence for portfolio prioritization. The platform turns multimodal data into evidence, reduces risk, and builds conviction, particularly for validating AI-driven hypotheses with multimodal evidence. It also offers secure, compliant Trusted Research Environments (TREs) and tech-enabled services for managing and analyzing large-scale, complex scientific datasets.",
    "primary_audience": "Global life science firms, pharmaceutical companies, biotech companies, research institutes, bioinformaticians, and scientists involved in drug discovery, disease understanding, and translational medicine.",
    "core_product": "The REVEAL Multimodal Evidence Platform, built on the SciDB computational database management system. This platform includes data schema for essential multimodal biological data entities, reference and annotation data, public datasets, science-level APIs, GUIs, Jupyter notebooks with workflows, Burst Mode for elastic scalability, use-case specific application packages, DataTrail for data provenance and reproducibility, and BioLens for interactive probing and visualization of genetic association study results. Additionally, Paradigm4 offers flexFS, a supercharged cloud file system, and a Trusted Research Environment (TRE).",
    "pricing_model": {
      "kind": "custom",
      "detail": "Pricing is not publicly disclosed and is likely custom, given the enterprise nature of its solutions and the absence of standard pricing plans on its official website or in public sources."
    },
    "parent_ownership": "Paradigm4 is a privately held, venture capital-backed company. It was co-founded by Marilyn Matz and Turing Award winner and MIT Professor Michael Stonebraker."
  },
  "intentTags": null,
  "businessProfileClaims": [],
  "timestamp": 1790493993522
}